Literature DB >> 7652738

Early-onset pauciarticular juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter.

J P Haas1, A Kimura, H Truckenbrodt, J Suschke, T Sasazuki, A Volgger, E D Albert.   

Abstract

Early-onset pauciarticular juvenile chronic arthritis (EOPA-JCA) has associations with different alleles of the MHC region (HLA-A2, DR5, 6, 8, DQA1*0401, *0501, *0601 and DPB1*0201). All susceptible DQA1 alleles carry an exclusive sequence motif. MHC-class II gene expression is controlled by 5' flanking upstream regulatory regions (URR). A hypervariable region in the promoter region of the HLA-DQA1 gene (-240 and -200 base pairs upstream) defines ten different QAP (DQA1-Promoter) alleles, which are associated with certain DQA1-alleles. The Y-Box in the DQA1 promoter (YC-Box -125 to -115 upstream from the ATG) differs from the consensus sequence (-123 A for G) of all other MHC class II Y-Boxes, resulting in a lower affinity to the NF-Y transcription factor and in a reduced expression of DQA1. A second substitution in the Y-Box of QAP 4.1 and 4.2 (-119 A for G) is found in the promoter alleles of the DQA1-alleles (DQA1*0401, *0501, *0601) and is strongly associated with susceptibility to EOPA-JCA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652738     DOI: 10.1111/j.1399-0039.1995.tb02460.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Ancient polymorphism and functional variation in the primate MHC-DQA1 5' cis-regulatory region.

Authors:  Dagan A Loisel; Matthew V Rockman; Gregory A Wray; Jeanne Altmann; Susan C Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

4.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

Review 5.  Pathogenesis of juvenile chronic arthritis: genetic and environmental factors.

Authors:  K Murray; S D Thompson; D N Glass
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

6.  Cis-regulatory evolution in a wild primate: Infection-associated genetic variation drives differential expression of MHC-DQA1 in vitro.

Authors:  Noah D Simons; Geeta N Eick; Maria J Ruiz-Lopez; Patrick A Omeja; Colin A Chapman; Tony L Goldberg; Nelson Ting; Kirstin N Sterner
Journal:  Mol Ecol       Date:  2017-07-24       Impact factor: 6.185

7.  The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis.

Authors:  K Alsaeid; M Z Haider; P N Sharma; E M Ayoub
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

8.  A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection.

Authors:  T Höhler; A Kruger; G Gerken; P M Schneider; K H Meyer zum Büschenefelde; C Rittner
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 9.  [Genetic background of juvenile idiopathic arthritis].

Authors:  J P Haas
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

10.  Do infections trigger juvenile idiopathic arthritis?

Authors:  Mustafa Aslan; Ozgur Kasapcopur; Hatice Yasar; Erdal Polat; Suat Saribas; Huseyin Cakan; Ahmet Dirican; Müzeyyen Mamal Torun; Nil Arısoy; Bekir Kocazeybek
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.